logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Blundy, Keith Stuart, Dr
    Born in April 1960
    Individual (4 offsprings)
    Officer
    icon of calendar 2022-11-18 ~ now
    OF - Director → CIF 0
  • 2
    Collins, Ian James, Dr
    Born in May 1967
    Individual (1 offspring)
    Officer
    icon of calendar 2023-12-19 ~ now
    OF - Director → CIF 0
  • 3
    Sore, Hannah Fiona, Dr
    Born in July 1977
    Individual (3 offsprings)
    Officer
    icon of calendar 2016-10-17 ~ now
    OF - Director → CIF 0
  • 4
    Dancer, Jane Elizabeth, Dr
    Born in February 1963
    Individual (6 offsprings)
    Officer
    icon of calendar 2019-12-11 ~ now
    OF - Director → CIF 0
  • 5
    Ford, David Ian
    Born in June 1974
    Individual (11 offsprings)
    Officer
    icon of calendar 2025-01-15 ~ now
    OF - Director → CIF 0
  • 6
    Moore, Jeffrey Bernard, Mr.
    Born in September 1965
    Individual (2 offsprings)
    Officer
    icon of calendar 2022-11-18 ~ now
    OF - Director → CIF 0
Ceased 5
  • 1
    Martin, Christine Janet, Dr
    Head Of Life Science Investment born in December 1969
    Individual (3 offsprings)
    Officer
    icon of calendar 2020-04-29 ~ 2022-11-18
    OF - Director → CIF 0
  • 2
    Mcpartland, Peter
    Company Director born in January 1954
    Individual (2 offsprings)
    Officer
    icon of calendar 2020-04-29 ~ 2025-01-15
    OF - Director → CIF 0
  • 3
    Fryers, Gaynor Mary
    Independent Consultant born in March 1957
    Individual (1 offspring)
    Officer
    icon of calendar 2019-04-06 ~ 2023-11-29
    OF - Director → CIF 0
  • 4
    Dr Hannah Fiona Sore
    Born in July 1977
    Individual (3 offsprings)
    Person with significant control
    icon of calendar 2016-10-17 ~ 2020-05-01
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 5
    Mateu, Natalia, Dr
    Scientist born in August 1983
    Individual
    Officer
    icon of calendar 2017-07-18 ~ 2022-11-18
    OF - Director → CIF 0
    Dr Natalie Mateu
    Born in August 1983
    Individual
    Person with significant control
    icon of calendar 2017-07-18 ~ 2020-05-01
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

PHARMENABLE THERAPEUTICS LIMITED

Previous name
PHARMENABLE LIMITED - 2023-07-20
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Property, Plant & Equipment
6,328 GBP2025-03-31
6,201 GBP2024-03-31
Debtors
398,989 GBP2025-03-31
660,757 GBP2024-03-31
Cash at bank and in hand
1,709,616 GBP2025-03-31
3,652,773 GBP2024-03-31
Current Assets
2,108,605 GBP2025-03-31
4,313,530 GBP2024-03-31
Creditors
Current, Amounts falling due within one year
-172,279 GBP2024-03-31
Net Current Assets/Liabilities
1,938,626 GBP2025-03-31
4,141,251 GBP2024-03-31
Total Assets Less Current Liabilities
1,944,954 GBP2025-03-31
4,147,452 GBP2024-03-31
Equity
Called up share capital
32 GBP2025-03-31
32 GBP2024-03-31
Share premium
8,019,741 GBP2025-03-31
8,019,741 GBP2024-03-31
Retained earnings (accumulated losses)
-6,074,819 GBP2025-03-31
-3,872,321 GBP2024-03-31
Equity
1,944,954 GBP2025-03-31
4,147,452 GBP2024-03-31
Average Number of Employees
172024-04-01 ~ 2025-03-31
172023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
Other
30,762 GBP2025-03-31
27,800 GBP2024-03-31
Property, Plant & Equipment - Other Disposals
Other
-1,593 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
24,434 GBP2025-03-31
21,599 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
4,424 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Other
-1,589 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Other
6,328 GBP2025-03-31
6,201 GBP2024-03-31
Amount of corporation tax that is recoverable
Current
278,016 GBP2025-03-31
450,794 GBP2024-03-31
Other Debtors
Amounts falling due within one year
120,973 GBP2025-03-31
209,963 GBP2024-03-31
Debtors
Amounts falling due within one year, Current
398,989 GBP2025-03-31
Current, Amounts falling due within one year
660,757 GBP2024-03-31
Trade Creditors/Trade Payables
Current
96,395 GBP2025-03-31
85,298 GBP2024-03-31
Other Creditors
Current
73,584 GBP2025-03-31
86,981 GBP2024-03-31
Creditors
Current
169,979 GBP2025-03-31
172,279 GBP2024-03-31

  • PHARMENABLE THERAPEUTICS LIMITED
    Info
    PHARMENABLE LIMITED - 2023-07-20
    Registered number 10430444
    icon of addressC/o Azets, Compass House, Vision Park, Histon, Cambridge, Cambridgeshire CB24 9AD
    PRIVATE LIMITED COMPANY incorporated on 2016-10-17 (9 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-25
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.